Goldman Sachs’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.47M Buy
+3,100
New +$1.56M ﹤0.01% 4798
2025
Q2
Sell
-72,200
Closed -$24.9M 6219
2025
Q1
$24.9M Buy
72,200
+46,000
+176% +$14.8M ﹤0.01% 1811
2024
Q4
$7.86M Hold
26,200
﹤0.01% 3022
2024
Q3
$10.6M Buy
26,200
+25,000
+2,083% +$9.15M ﹤0.01% 2643
2024
Q2
$386K Hold
1,200
﹤0.01% 4971
2024
Q1
$400K Buy
+1,200
New +$367K ﹤0.01% 4850
2023
Q2
Sell
-34,100
Closed -$8.99M 5879
2023
Q1
$8.99M Buy
+34,100
New +$8.66M ﹤0.01% 2517
2022
Q1
Sell
-18,300
Closed -$4.7M 6698
2021
Q4
$4.7M Hold
18,300
﹤0.01% 3471
2021
Q3
$4.44M Hold
18,300
﹤0.01% 3458
2021
Q2
$3.78M Hold
18,300
﹤0.01% 3600
2021
Q1
$3.45M Sell
18,300
-7,100
-28% -$1.25M ﹤0.01% 3481
2020
Q4
$4.18M Sell
25,400
-27,500
-52% -$4.02M ﹤0.01% 3137
2020
Q3
$6.6M Buy
52,900
+34,600
+189% +$4.28M ﹤0.01% 2684
2020
Q2
$1.78M Hold
18,300
﹤0.01% 3543
2020
Q1
$1.64M Buy
+18,300
New +$2.37M ﹤0.01% 3438
2019
Q1
Sell
-2,200
Closed -$274K 5264
2018
Q4
$274K Hold
2,200
﹤0.01% 4679
2018
Q3
$306K Hold
2,200
﹤0.01% 4704
2018
Q2
$226K Hold
2,200
﹤0.01% 4944
2018
Q1
$213K Sell
2,200
-44,100
-95% -$4.28M ﹤0.01% 4970
2017
Q4
$4.07M Sell
46,300
-24,800
-35% -$1.99M ﹤0.01% 3199
2017
Q3
$5.66M Buy
71,100
+24,700
+53% +$1.99M ﹤0.01% 3032
2017
Q2
$4.05M Sell
46,400
-93,700
-67% -$7.93M ﹤0.01% 3238
2017
Q1
$12.5M Buy
140,100
+87,600
+167% +$7.3M ﹤0.01% 2242
2016
Q4
$3.89M Sell
52,500
-77,800
-60% -$5.83M ﹤0.01% 3269
2016
Q3
$9.86M Buy
130,300
+81,500
+167% +$6.24M ﹤0.01% 2460
2016
Q2
$3.76M Buy
48,800
+26,000
+114% +$2.05M ﹤0.01% 3098
2016
Q1
$1.78M Sell
22,800
-1,037,500
-98% -$72.4M ﹤0.01% 3588
2015
Q4
$71.7M Sell
1,060,300
-624,600
-37% -$43.6M 0.02% 865
2015
Q3
$130M Sell
1,684,900
-372,300
-18% -$33M 0.04% 489
2015
Q2
$187M Buy
2,057,200
+910,700
+79% +$73M 0.06% 368
2015
Q1
$86.3M Sell
1,146,500
-394,600
-26% -$28.3M 0.03% 725
2014
Q4
$113M Buy
1,541,100
+428,800
+39% +$30.1M 0.04% 608
2014
Q3
$78.4M Buy
1,112,300
+703,000
+172% +$46.5M 0.02% 771
2014
Q2
$23.1M Buy
409,300
+127,900
+45% +$6.75M 0.01% 1677
2014
Q1
$14.8M Buy
281,400
+210,400
+296% +$10.5M ﹤0.01% 2022
2013
Q4
$3.39M Sell
71,000
-171,300
-71% -$7.92M ﹤0.01% 3515
2013
Q3
$10.4M Sell
242,300
-193,100
-44% -$7.55M ﹤0.01% 2210
2013
Q2
$15.7M Buy
+435,400
New +$16.8M 0.01% 1708

Other funds holding HCA

Goldman Sachs's HCA Position: Q1 2026 in Review

Goldman Sachs increased its HCA Healthcare (HCA) stake by 21% in Q1 2026, buying an estimated $183M and bringing the position to 2,136,072 shares worth $1.01B. The position accounts for 0.12% of the portfolio, ranked #166.

Goldman Sachs first reported a position in HCA in Q2 2013 and has held it in 52 quarters since. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Goldman Sachs held 2,136,072 shares of HCA Healthcare worth $1.01B as of Q1 2026.
  • Goldman Sachs bought 363,729 HCA Healthcare shares in Q1 2026, an estimated $183M.
  • HCA Healthcare made up 0.12% of Goldman Sachs's portfolio in Q1 2026, its #166 holding.
  • Goldman Sachs first reported a position in HCA Healthcare in Q2 2013 and has held it in 52 quarters since.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.